They found that sufficient inhibition of gastric acid by omeprazole inhibited both ulcer recurrence and responses, which suggested that acid may enhance gastric mucosal inflammation in response to IL1-β stimulation, resulting in gastric ulcers. Here, IL1B is linked to ulcer disease.